cancer
The Chairman asked the Food and Drug Administration (FDA) of a action Starker € €? to combat the lack of some important medicines. In the list of medications to the lowest bid is the chemotherapy drug isolating, one of the most commonly used drugs for the treatment of mesothelioma. mesothelioma
Mesothelioma is a rare but deadly form of cancer caused by asbestos, which caused about 2,500 Americans each year suffer. Isolating in combination with penetrated (Lima) is FDA approved as first-line treatment of malignant pleural mesothelioma.
In a press conference in Washington last week, the Minister of Health and Social Services, Kathleen Rebellious, said the number of shortages of prescription drugs, such as isolating has tripled from 2005 to 2010. According to the FDA, so far this year, the number of drug shortages has increased from 178,200 in 2010. mesothelioma
Isolating is used both for both pleural mesothelioma and peritoneal mesothelioma (off-label). The drug is scarce, partly because of its popularity, not only of mesothelioma, but also for other types of cancer, the most common, including testicular, bladder and ovarian cancer.asbestos
Since isolating patents has expired and is now available in generic form, Bristol-Myers Squibb has ceased, the brand name version of the drug. Generic drugs are much less profitable for pharmaceutical companies, leading some to adjust to production, leading to shortages.
Among other things, the new regulation requires companies to give more notice if they intend to stop the production of a drug such as isolating and calls on the FDA to expedite the review and approval of new drug manufacturing plants.
The Obama administration called the decree a AA € ~ € ™ first STEP drug shortages. According to the New York Times, the government is also considering storing some important cancer drugs as insurance against future shocks production.asbestos
At the same time, the officials of the drugs have frequent with isolating for the treatment of mesothelioma combined received a boost with the European standards. Eli Lilly has approved the message that penetrated was for continuation maintenance therapy for patients with advanced NCIC of squeamish cells recently.
Although penetrated is not unusual, it is expensive (about $ 1700 per bottle), a situation that could meet the new regulation. No word yet on the impact of market expansion Lima € ™ could be found on their availability for the treatment of mesothelioma.